Biozipcode ^None

Biozipcode is a company focused on developing therapeutic drugs and technology that can completely cure diabetes, rather than just treating symptoms. They aim to deliver drugs to specific cells using cell-targeting technology. The company works with pharmaceutical and health food manufacturers, as well as research institutions, to support their product development and research. The research is led by Professor Hidehito Koijima, a special professor at Shiga University of Medical Science. Biozipcode is actively seeking funding, recruiting talent, and building partnerships to develop a cure for diabetes and expand their business globally.